Mirum Pharmaceuticals Announces $600M Convertible Bond Sale; Shares Slip in After-Hours Trading
Mirum Pharmaceuticals revealed a private placement of $600 million in convertible bonds due 2032, and said it will use some proceeds together with common stock issuance to exchange a portion of its existing 4% convertible bonds due 2029. The announcement coincided with a 2% drop in extended trading, while the stock had closed the regular session hi…